Sotera Health (NASDAQ:SHC) Hits New 52-Week Low at $10.72

Sotera Health (NASDAQ:SHC - Get Free Report)'s stock price hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $10.72 and last traded at $10.75, with a volume of 980611 shares. The stock had previously closed at $10.89.

Analyst Ratings Changes

Several equities analysts have commented on SHC shares. Citigroup raised shares of Sotera Health from a "neutral" rating to a "buy" rating and decreased their target price for the company from $18.00 to $16.00 in a report on Wednesday, April 3rd. Jefferies Financial Group raised shares of Sotera Health from a "hold" rating to a "buy" rating and lifted their price objective for the company from $15.00 to $15.50 in a research note on Monday, March 25th. KeyCorp started coverage on Sotera Health in a research note on Tuesday, February 6th. They set a "sector weight" rating for the company. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $20.00 target price on shares of Sotera Health in a report on Monday, March 4th. Finally, Barclays lowered their price target on Sotera Health from $19.00 to $14.00 and set an "overweight" rating for the company in a report on Wednesday, April 10th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $17.70.

Sotera Health Trading Down 1.3 %

The company has a debt-to-equity ratio of 5.16, a current ratio of 2.42 and a quick ratio of 2.21. The firm has a market cap of $3.04 billion, a price-to-earnings ratio of 59.72 and a beta of 2.11. The firm's fifty day moving average is $13.71 and its 200-day moving average is $14.25.

Sotera Health (NASDAQ:SHC - Get Free Report) last issued its quarterly earnings results on Tuesday, February 27th. The company reported $0.26 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.26. The firm had revenue of $310.24 million for the quarter, compared to analyst estimates of $302.17 million. Sotera Health had a return on equity of 51.32% and a net margin of 4.90%. The company's revenue was up 23.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.23 earnings per share. Equities analysts anticipate that Sotera Health will post 0.64 earnings per share for the current year.

Insider Activity

In other Sotera Health news, Director Pincus & Co. Warburg sold 16,594,363 shares of the company's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.31, for a total transaction of $237,465,334.53. Following the transaction, the director now owns 88,822,952 shares in the company, valued at $1,271,056,443.12. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In related news, insider Michael P. Rutz sold 83,109 shares of the stock in a transaction on Monday, March 4th. The stock was sold at an average price of $14.31, for a total value of $1,189,289.79. Following the completion of the sale, the insider now directly owns 544,409 shares of the company's stock, valued at approximately $7,790,492.79. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, Director Pincus & Co. Warburg sold 16,594,363 shares of the firm's stock in a transaction on Monday, March 4th. The shares were sold at an average price of $14.31, for a total value of $237,465,334.53. Following the transaction, the director now owns 88,822,952 shares in the company, valued at $1,271,056,443.12. The disclosure for this sale can be found here. Corporate insiders own 65.13% of the company's stock.

Hedge Funds Weigh In On Sotera Health

Hedge funds and other institutional investors have recently modified their holdings of the business. Acadian Asset Management LLC bought a new position in Sotera Health during the first quarter valued at about $30,000. BNP Paribas Arbitrage SNC purchased a new position in Sotera Health in the third quarter valued at about $37,000. Jefferies Financial Group Inc. bought a new position in shares of Sotera Health during the 4th quarter valued at approximately $43,000. Osaic Holdings Inc. increased its stake in shares of Sotera Health by 100.7% during the 2nd quarter. Osaic Holdings Inc. now owns 2,549 shares of the company's stock worth $48,000 after purchasing an additional 1,279 shares during the last quarter. Finally, Wells Fargo & Company MN raised its holdings in shares of Sotera Health by 30.7% in the 4th quarter. Wells Fargo & Company MN now owns 6,455 shares of the company's stock worth $54,000 after purchasing an additional 1,518 shares during the period. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.